LYEL logo

Lyell Immunopharma, Inc. Common Stock


LYEL: Lyell Immunopharma Inc is a T cell reprogramming company dedicated towards the mastery of T cells to eradicate solid tumors. Its pipeline includes CARs (Chimeric antigen receptors), TILs (Tumor-infiltrating lymphocytes), and TCRs (T cell receptors).


Show LYEL Financials

Consumer Interest
SEC Filings

Recent trades of LYEL by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard

Recently reported changes by institutional investors

Quiver Logo

No Whale Activity for this ticker

Institutional Holdings Dashboard

Quarterly net insider trading by LYEL's directors and management

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard
U.S. Patents

New patents grants

Quiver Logo

No new patents for this ticker

U.S. Patents Dashboard
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard

Number of mentions of LYEL in WallStreetBets Daily Discussion


Recent insights relating to LYEL

CNBC Recommendations

Recent picks made for LYEL stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in LYEL

Corporate Flights

Flights by private jets registered to LYEL